EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''

Mohamed Moussa, Dave Sprengers, M J Sonneveld

Digestive and Liver Disease · 2026-11

DOI: 10.1016/j.dld.2026.10.034 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Digestive and Liver Disease, 2026-11. Verfasst von Mohamed Moussa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: m.moussa@erasmu…. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: m.moussa@erasmusmc.nl.
  • Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Zitieren

APA

Moussa, M., Sprengers, D., & Sonneveld, M. J. (2026). Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.10.034

Vancouver

Moussa M, Sprengers D, Sonneveld MJ. Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.10.034

BibTeX
@article{Moussa2026,
  author = {Moussa, Mohamed and Sprengers, Dave and Sonneveld, M J},
  title = {Author’s Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''},
  journal = {Digestive and Liver Disease},
  year = {2026},
  doi = {10.1016/j.dld.2026.10.034}
}
Kostenlos starten →